Page last updated: 2024-12-05

1,3-dichlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,3-Dichlorobenzene: A Versatile Tool in Research

1,3-Dichlorobenzene, also known as m-dichlorobenzene, is an organic compound with the formula C6H4Cl2. It's a colorless liquid with a sweet, aromatic odor and is used in various scientific research applications.

Here's why it's important:

**1. Versatile Solvent:**

* **High boiling point:** 1,3-Dichlorobenzene has a high boiling point (172 °C), making it suitable for dissolving and reacting high-boiling point compounds that wouldn't dissolve in common solvents like ethanol or diethyl ether.
* **Aromatic nature:** Its aromatic structure allows it to dissolve a wide range of organic compounds, including many pharmaceuticals and natural products.
* **Non-polar:** Its non-polar nature makes it an ideal solvent for reactions involving hydrophobic molecules.

**2. Reagent in Chemical Reactions:**

* **Chlorination:** 1,3-Dichlorobenzene can be used as a source of chlorine in various chlorination reactions.
* **Catalyst:** It can act as a catalyst in some organic reactions, particularly in the production of polymers and pharmaceuticals.
* **Intermediate:** It serves as an intermediate in the synthesis of various compounds, including pesticides, herbicides, and dyes.

**3. Research Applications:**

* **Organic synthesis:** It's widely used in organic synthesis for reactions involving Grignard reagents, Friedel-Crafts reactions, and other reactions requiring a high-boiling point solvent.
* **Materials science:** It's employed in the synthesis and characterization of new materials, including polymers, nanoparticles, and composites.
* **Analytical chemistry:** 1,3-Dichlorobenzene is used as a solvent for various analytical techniques like chromatography and spectroscopy.

**4. Environmental Studies:**

* **Pollution studies:** It's used as a tracer in environmental studies to track the movement of pollutants in soil and water.
* **Biodegradation research:** Scientists study its biodegradation by microorganisms to understand how it breaks down in the environment.

**5. Biological Studies:**

* **Toxicity studies:** 1,3-Dichlorobenzene is used in toxicological studies to evaluate its potential effects on organisms.
* **Drug development:** It's been investigated for its potential use as a drug, specifically for its anti-inflammatory properties.

**Important Notes:**

* 1,3-Dichlorobenzene is a **toxic and flammable** compound, requiring proper handling and safety precautions in research laboratories.
* Its **environmental impact** is a concern due to its persistence in the environment and potential bioaccumulation in organisms.

**In summary, 1,3-Dichlorobenzene is a versatile compound with numerous applications in research due to its unique properties as a solvent, reagent, and intermediate. Its importance in various scientific fields makes it a valuable tool for advancing our understanding of chemistry, materials science, and environmental processes.**

1,3-dichlorobenzene : A dichlorobenzene carrying chloro substituents at positions 1 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10943
CHEMBL ID45235
CHEBI ID36693
SCHEMBL ID28140
MeSH IDM0124622

Synonyms (73)

Synonym
AKOS009031576
benzene, 1,3-dichloro-
meta-dichlorobenzene
CHEBI:36693 ,
metadichlorobenzene
inchi=1/c6h4cl2/c7-5-2-1-3-6(8)4-5/h1-4
1,3-dichlorobenzene
m-dichlorobenzol
nsc-8754
m-phenylene dichloride
m-dichlorobenzene
541-73-1
benzene, m-dichloro-
nsc8754
NCGC00091197-01
ai3-15517
m-phenylenedichloride
nsc 8754
m-dcb
rcra waste no. u071
ccris 4259
einecs 208-792-1
hsdb 522
2,4-dichlorobenzene
1,3-dichlorobenzene, 98%
1,3-dichlorobenzene, puriss., >=99.0% (gc)
46536A91-5C63-4685-94E2-E2FAB9C3B34D
D0333
1,3-dichloro-benzene
CHEMBL45235
MLS001050090
smr001216526
S0665
NCGC00091197-03
NCGC00091197-02
benzene, 1,3-dichloro-, radical ion(1-)
63697-17-6
C19397
dtxcid102056
NCGC00253960-01
tox21_202179
NCGC00259728-01
dtxsid6022056 ,
tox21_300005
cas-541-73-1
1,3-bis(chloranyl)benzene
A830009
ec 208-792-1
unii-75w0wne5fp
75w0wne5fp ,
FT-0606649
m-dichlorobenzene [mi]
dichlorobenzene, m-
1,3-dichlorobenzene [hsdb]
meta-dichlorobenzene [iarc]
SCHEMBL28140
1,3-dichorobenzene
m-dichlorobenzen
1.3-dichlorobenzene
J-503894
CS-B0931
2,6-dichlorobenzene
F0001-1423
mfcd00000573
1,3-dichlorobenzene, pestanal(r), analytical standard
1,3-dichlorobenzene 10 microg/ml in cyclohexane
1,3-dichlorobenzene 100 microg/ml in methanol
Q2216854
AS-12418
AMY3617
D77223
EN300-20468
PD124140

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Therefore, a direct or indirect effect of VTG on the GSI is suggested rather than a direct toxic effect of the tested compounds on the gonads."( In vitro and in vivo estrogenicity and toxicity of o-, m-, and p-dichlorobenzene.
Arijs, K; Janssen, CR; Lema, W; Verslycke, T; Versonnen, BJ, 2003
)
0.32

Dosage Studied

ExcerptRelevanceReference
" In the liver of the DL-buthionine-(S,R)-sulfoximine (BSO)-treated rats dosed with m-DCB, both of 2,4- and 3,5-DCPSO2Mes were present at significantly lower concentrations than in non-BSO-treated rats."( Contribution of methylsulfonyl metabolites of m-dichlorobenzene to the heme metabolic enzyme induction by the parent compound in rat liver.
Kato, Y; Kimura, R; Kogure, T; Sato, M, 1988
)
0.27
" In the antibiotic-pretreated rats dosed with m-DCB, metabolite concentrations in the blood and the three tissues markedly decreased."( Evidence that methylsulfonyl metabolites of m-dichlorobenzene are causative substances of induction of hepatic microsomal drug-metabolizing enzymes by the parent compound in rats.
Kato, Y; Kimura, R; Kogure, T; Murata, T; Sato, M, 1986
)
0.27
" In the blood, urine and feces of rats dosed with m-DCB, 2,4- and 3,5-dichlorophenyl methyl sulfoxides and 3,5- and 2,4-dichlorophenyl methyl sulfones emerged, while their possible precursors, 3,5- and 2,4-dichlorophenyl methyl sulfides (Me' and Mf', respectively), were not detected in the blood, urine and feces."( Identification of sulfur-containing metabolites of m-dichlorobenzene and their disposition and relationship with glutathione in rats.
Itagaki, K; Kimura, R; Kogure, T; Murata, T; Sano, H; Sato, M, 1984
)
0.27
" Dose-response studies indicated that the rank order for acute hepatotoxicity of the isomers was m-DCB > o-DCB > or = p-DCB."( Isomer-specific acute toxicity and cell proliferation in livers of B6C3F1 mice exposed to dichlorobenzene.
Kurokawa, Y; Saito, M; Takagi, A; Umemura, T, 1996
)
0.29
" There were clear dose-response relations for all investigated parameters."( Excretion kinetics of 1,3-dichlorobenzene and its urinary metabolites after controlled airborne exposure in human volunteers.
Bertram, J; Christoforou, R; Esser, A; Krabbe, J; Kraus, T; Möller, M; Schettgen, T; Schweiker, M; Ziegler, P, 2023
)
1.22
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
1,3-dichlorobenzene degradation57

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency54.54463.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency14.60150.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency6.29630.000221.22318,912.5098AID1259247; AID743042
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency72.25650.000657.913322,387.1992AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.45670.001022.650876.6163AID1224838; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency36.19930.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency15.37280.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.72700.001530.607315,848.9004AID1224841; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency24.54120.375827.485161.6524AID743220
estrogen nuclear receptor alphaHomo sapiens (human)Potency42.60400.000229.305416,493.5996AID1259244; AID1259248
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency30.823019.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency54.54460.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency62.38230.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.10160.000323.4451159.6830AID743065
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency33.49150.000627.21521,122.0200AID651741
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency68.10160.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency68.10160.001551.739315,848.9004AID1259244
Nuclear receptor ROR-gammaHomo sapiens (human)Potency0.33490.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (50)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (18.00)18.7374
1990's16 (32.00)18.2507
2000's12 (24.00)29.6817
2010's11 (22.00)24.3611
2020's2 (4.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.84 (24.57)
Research Supply Index4.01 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index64.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (92.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]